INTENSITY-MODULATED PROTON THERAPY MARKET ANALYSIS

Regional Analysis

Global Intensity-Modulated Proton Therapy Market- Regional Analysis

On the basis of region, the global intensity modulated proton therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The burden of cancer is growing across North America, and various organizations such as Pan America Health Organization (PAHO) are operating in North America to reduce cancer mortality. Major players in the market are focused on research and development which is expected to drive global intensity modulated proton therapy market growth during forecast period. For instance, in 2018, Varian Medical System, a radiation oncology treatments and software maker, introduced a single room intensity modulated proton therapy system called 'ProBeam 360' at the 2018 American Society of Radiation Oncology meeting.

Moreover, in Europe, cancer is the highest cause of death and morbidity. For instance, According to the European Journal of Cancer, in 2018, Cancer accounted for 1.9 million deaths in Europe. Therefore, the increasing disease prevalence in the region is expected to create growth opportunities for players to introduce oncology treatments and expand their presence. Market players are focusing on strategies such as acquisitions and mergers in order to strengthen their market share in global intensity modulated proton therapy market. For instance, in January 2020, Ion Beam Application S.A, a leading provider of proton therapy solutions, announced that the company has signed a contract with International Charity Foundation Cartu, the largest charity organization in Georgia. The contract includes clinical use of Proteus ONE solution for scientific research in campus of Kutaisi International University, in Georgia.

Furthermore, the increasing number of healthcare facilities offering intensity modulated proton therapy in Asia Pacific is expected to favor growth of the global intensity modulated proton therapy market in the region. For instance, in 2019, Apollo Hospitals Enterprise Limited, an Indian hospital chain, started the Apollo Proton Cancer Centre (APCC) in India equipped with intensity modulated proton therapy and image guided radiotherapy.